Effect of Negative Wound Pressure on P.S
Launched by ASSIUT UNIVERSITY · Jan 29, 2024
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a treatment called Negative Pressure Wound Therapy (NPWT) on pressure sores, which are injuries to the skin that can occur when someone is in one position for too long. The researchers want to compare this new treatment to regular wound dressings to see which one helps wounds heal better. They will look at how much the wounds shrink, how deep they become, and how well new healthy tissue forms.
To participate in this study, individuals need to have pressure sores that are at stages three or four, which means the wounds are more severe and have a greater chance of complications. Unfortunately, people with certain conditions, like wounds that cannot be cleaned properly or those with severe bleeding, will not be eligible to join. If someone is chosen for the trial, they will receive either the NPWT or standard dressings and will be monitored to see how well their wounds heal over time. The trial is not currently recruiting participants, but it aims to provide insights that could improve the treatment of pressure sores in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Stages three and four PU as defined by the National Pressure Ulcer Advisory Panel (NPUAP).
- Exclusion Criteria:
- • wound with necrotic tissue unlikely to tolerate debridement. Exposed Vessels, Nerves and or organs. Active bleeding. Ischemic limb. Opening into body cavity
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
assem hussien, professor
Principal Investigator
Assiut University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported